Our story

Company

Finnish clinical phase biopharma company with over 20 years of history in biological drug development. The Company is focused on development and commercialization of its proprietary technology platform: Gene Transport Unit (GTU®). Currently, the Company employs 12 persons (+CEO) and has an experienced management as well as an internationally recognized scientific advisory board

History

FIT Biotech was at first focused on development project of a HIV vaccine. GTU® technology platform was discovered during the project. As the commercial potential of GTU® emerged, the company shifted its strategy.

Future

FIT Biotech is a technology company actively seeking application opportunities for GTU® and targeting licensing agreements with big pharma.

history_today_future